TY - JOUR
T1 - Post-Covid-19 condition (Long Covid) in children and young people 12 months after infection or reinfection with the Omicron variant
T2 - a prospective observational study
AU - Pinto Pereira, Snehal M.
AU - Nugawela, Manjula D.
AU - Stephenson, Terence
AU - Foret-Bruno, Paul
AU - Dalrymple, Emma
AU - Xu, Laila
AU - Whittaker, Elizabeth
AU - Heyman, Isobel
AU - Ford, Tamsin
AU - Segal, Terry
AU - Chalder, Trudie
AU - Ladhani, Shamez N.
AU - Mensah, Anna A.
AU - McOwat, Kelsey
AU - Simmons, Ruth
AU - Shafran, Roz
AU - Buszewicz, Marta
AU - Crawley, Esther
AU - Garg, Shruti
AU - Hargreaves, Dougal
AU - Harnden, Anthony
AU - Levin, Michael
AU - Poustie, Vanessa
AU - Semple, Malcolm
AU - Sharma, Kishan
AU - De Stavola, Bianca
AU - Swann, Olivia
N1 - Publisher Copyright:
© The Author(s) 2024.
PY - 2024/12
Y1 - 2024/12
N2 - Our previous study in children and young people (CYP) at 3- and 6-months post-infection showed that 12–16% of those infected with the Omicron (B.1.1.529) variant of SARS-CoV-2 met the research definition of Long Covid, with no differences between first-positive and reinfected CYP. The primary objective of the current study is to explore the impact of the Omicron variant of SARS-CoV-2 infection on young people 12 months post infection. 345 CYP aged 11–17 years with a first laboratory-confirmed infection with the Omicron variant and 360 CYP reinfected with the Omicron variant completed an online questionnaire assessing demographics, symptoms, and their impact shortly after testing and again at 3-, 6-and 12-months post-testing. Vaccination status was determined from information held at UKHSA. Comparisons between groups were made using chi-squared, Mann–Whitney U, and Kruskal–Wallis tests. The most common symptoms in first-positive and reinfected CYP 12-months post-testing were tiredness (35.7 and 33.6% respectively) and sleeping difficulties (27.5 and 28.3% respectively). Symptom profiles, severity and impact were similar in the two infection status groups. Overall, by 12-months, 17.4% of first-positives and 21.9% of reinfected CYP fulfilled the research consensus Long Covid definition (p = 0.13). 12-months post Omicron infection, there is little difference between first-positive and reinfected CYP with respect to symptom profiles and impact. Clinicians may not therefore need to consider number of infections and type of variant when developing treatment plans. Further studies are needed to assess causality of reported symptoms up to 12-months after SARS-CoV-2 infection.
AB - Our previous study in children and young people (CYP) at 3- and 6-months post-infection showed that 12–16% of those infected with the Omicron (B.1.1.529) variant of SARS-CoV-2 met the research definition of Long Covid, with no differences between first-positive and reinfected CYP. The primary objective of the current study is to explore the impact of the Omicron variant of SARS-CoV-2 infection on young people 12 months post infection. 345 CYP aged 11–17 years with a first laboratory-confirmed infection with the Omicron variant and 360 CYP reinfected with the Omicron variant completed an online questionnaire assessing demographics, symptoms, and their impact shortly after testing and again at 3-, 6-and 12-months post-testing. Vaccination status was determined from information held at UKHSA. Comparisons between groups were made using chi-squared, Mann–Whitney U, and Kruskal–Wallis tests. The most common symptoms in first-positive and reinfected CYP 12-months post-testing were tiredness (35.7 and 33.6% respectively) and sleeping difficulties (27.5 and 28.3% respectively). Symptom profiles, severity and impact were similar in the two infection status groups. Overall, by 12-months, 17.4% of first-positives and 21.9% of reinfected CYP fulfilled the research consensus Long Covid definition (p = 0.13). 12-months post Omicron infection, there is little difference between first-positive and reinfected CYP with respect to symptom profiles and impact. Clinicians may not therefore need to consider number of infections and type of variant when developing treatment plans. Further studies are needed to assess causality of reported symptoms up to 12-months after SARS-CoV-2 infection.
KW - Long Covid
KW - Omicron
KW - Post Covid-19 condition
KW - Prospective
KW - Young people
UR - http://www.scopus.com/inward/record.url?scp=85191728486&partnerID=8YFLogxK
U2 - 10.1038/s41598-024-60372-4
DO - 10.1038/s41598-024-60372-4
M3 - Article
C2 - 38693285
AN - SCOPUS:85191728486
SN - 2045-2322
VL - 14
JO - Scientific Reports
JF - Scientific Reports
IS - 1
M1 - 9957
ER -